Clinical Trial Update: WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for WJMSCs anti-inflammatory therapy in Coronary Artery Disease is underway but with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• WJMSCs anti-inflammatory therapy

Snippet

Sponsor: Navy General Hospital, Beijing | Conditions: Coronary Artery Disease | Phase 2 | Status: UNKNOWN